1. Home
  2. OXY vs BDX Comparison

OXY vs BDX Comparison

Compare OXY & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Occidental Petroleum Corporation

OXY

Occidental Petroleum Corporation

HOLD

Current Price

$57.10

Market Cap

58.5B

Sector

Energy

ML Signal

HOLD

Logo Becton Dickinson and Company

BDX

Becton Dickinson and Company

HOLD

Current Price

$146.68

Market Cap

51.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OXY
BDX
Founded
1920
1897
Country
United States
United States
Employees
10412
N/A
Industry
Oil & Gas Production
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.5B
51.5B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
OXY
BDX
Price
$57.10
$146.68
Analyst Decision
Hold
Buy
Analyst Count
21
13
Target Price
$57.71
$186.00
AVG Volume (30 Days)
10.2M
2.9M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
1.71%
2.89%
EPS Growth
N/A
N/A
EPS
N/A
0.25
Revenue
N/A
$21,840,000,000.00
Revenue This Year
$14.12
N/A
Revenue Next Year
N/A
$3.02
P/E Ratio
$29.26
$592.92
Revenue Growth
N/A
8.24
52 Week Low
$38.80
$141.82
52 Week High
$67.45
$213.08

Technical Indicators

Market Signals
Indicator
OXY
BDX
Relative Strength Index (RSI) 46.92 46.04
Support Level $52.35 $141.82
Resistance Level $60.77 $158.66
Average True Range (ATR) 1.61 4.57
MACD 0.05 0.70
Stochastic Oscillator 48.81 36.55

Price Performance

Historical Comparison
OXY
BDX

About OXY Occidental Petroleum Corporation

Occidental Petroleum is an independent exploration and production company with operations in the United States, Latin America, and the Middle East. At the end of 2025, the company reported net proved reserves of 4.6 billion barrels of oil equivalent. Net production averaged 1.4 million barrels of oil equivalent per day in 2025 at a ratio of roughly 74% oil and natural gas liquids and 26% natural gas.

About BDX Becton Dickinson and Company

Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. On a 2025 sales basis, following the spinoff, BD Medical Essentials represented 34% of revenue, the Interventional segment 28%, Connected Care 25%, and Biopharma 13%. International revenue accounts for 43% of the company's business.

Share on Social Networks: